Research Article

Naringin is Protective in Paclitaxel-Induced Peripheral Neuropathy; A Multi-Biomarker Approach

Volume: 4 Number: 3 September 21, 2023
EN

Naringin is Protective in Paclitaxel-Induced Peripheral Neuropathy; A Multi-Biomarker Approach

Abstract

Aim: Cancer is a disease that is on the rise worldwide. Paclitaxel (PTX) is one of the most common chemotherapeutic agents used in the treatment of many cancers. PTX causes toxic effects by increasing oxidative stress in tissues. Naringin is a powerful antioxidant found naturally in many plants, especially citrus fruits. The aim of this study was to determine the protective effects of NRG in PTX-induced sciatic nerve injury. Methods: Thirty-five male rats were randomly divided into five groups: control, PTX, NRG, PTX+NRG-50, PTX+NRG-100. PTX was administered i.p. for the first five days and NRG 50 or 100 mg/kg orally on days 6-14. Sciatic nerve tissues were harvested and analyzed for markers of oxidative stress, inflammation and apoptosis damage levels by biochemical methods. Results: PTX caused oxidative stress damage by increasing lipid peroxidation (MDA) and decreasing antioxidant capacity (SOD, CAT, GPx and GSH), inflammatory damage by increasing proinflammatory cytokine (NF-κB, TNF-α, IL-1β, SIRT1, TLR4, and NRF2) release, apoptotic damage by increasing apoptotic factor (Bax) and decreasing antiapoptotic factor (Bcl-2) in sciatic nerve tissue (p < 0.05). NRG, on the other hand, reversed all these changes in sciatic nerve tissue and reduced PTX-induced oxidative stress damage, inflammatory damage and apoptotic damage (p < 0.05). These effects were more effective at the 100 mg/kg dose of NRG than at the 50 mg/kg dose (p < 0.05). Conclusions: In sciatic nerve tissue, PTX induced peripheral neuropathy with increased oxidative stress, inflammation and apoptotic damage. NRG showed a protective effect against PTX-induced peripheral neuropathy.

Keywords

References

  1. 1. Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021; 134(7):783-91.
  2. 2. Choudhury H, Maheshwari R, Pandey M, Tekade M, Gorain B, Tekade RK. Advanced nanoscale carrier-based approaches to overcome biopharmaceutical issues associated with anticancer drug 'Etoposide'. Mater Sci Eng C Mater Biol Appl. 2020; 106:110275.
  3. 3. Semis HS, Kandemir FM, Kaynar O, Dogan T, Arikan SM. The protective effects of hesperidin against paclitaxel-induced peripheral neuropathy in rats. Life Sci. 2021; 287:120104.
  4. 4. Galley HF, McCormick B, Wilson KL, Lowes DA, Colvin L, Torsney C. Melatonin limits paclitaxel-induced mitochondrial dysfunction in vitro and protects against paclitaxel-induced neuropathic pain in the rat. J Pineal Res. 2017; 63(4):e12444.
  5. 5. Yardım A, Kandemir FM, Çomaklı S, et al. Protective Effects of Curcumin Against Paclitaxel-Induced Spinal Cord and Sciatic Nerve Injuries in Rats. Neurochem Res. 2021; 46(2):379-95.
  6. 6. Yang YH, Mao JW, Tan XL. Research progress on the source, production, and anti-cancer mechanisms of paclitaxel. Chin J Nat Med. 2020; 18(12):890-97.
  7. 7. Zhu L, Chen L. Progress in research on paclitaxel and tumor immunotherapy. Cell Mol Biol Lett. 2019; 24:40.
  8. 8. Klein I, Lehmann HC. Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy. Toxics. 2021; 9(10):229.

Details

Primary Language

English

Subjects

Biochemistry and Cell Biology (Other)

Journal Section

Research Article

Publication Date

September 21, 2023

Submission Date

July 10, 2023

Acceptance Date

August 12, 2023

Published in Issue

Year 2023 Volume: 4 Number: 3

APA
Yılmaz, S., Şimşek, H., Küçükler, S., Aygörmez, S., Erdoğan, E., & Kandemir, F. M. (2023). Naringin is Protective in Paclitaxel-Induced Peripheral Neuropathy; A Multi-Biomarker Approach. New Trends in Medicine Sciences, 4(3), 149-155. https://doi.org/10.56766/ntms.1325124
AMA
1.Yılmaz S, Şimşek H, Küçükler S, Aygörmez S, Erdoğan E, Kandemir FM. Naringin is Protective in Paclitaxel-Induced Peripheral Neuropathy; A Multi-Biomarker Approach. New Trend Med Sci. 2023;4(3):149-155. doi:10.56766/ntms.1325124
Chicago
Yılmaz, Selçuk, Hasan Şimşek, Sefa Küçükler, Serpil Aygörmez, Ender Erdoğan, and Fatih Mehmet Kandemir. 2023. “Naringin Is Protective in Paclitaxel-Induced Peripheral Neuropathy; A Multi-Biomarker Approach”. New Trends in Medicine Sciences 4 (3): 149-55. https://doi.org/10.56766/ntms.1325124.
EndNote
Yılmaz S, Şimşek H, Küçükler S, Aygörmez S, Erdoğan E, Kandemir FM (September 1, 2023) Naringin is Protective in Paclitaxel-Induced Peripheral Neuropathy; A Multi-Biomarker Approach. New Trends in Medicine Sciences 4 3 149–155.
IEEE
[1]S. Yılmaz, H. Şimşek, S. Küçükler, S. Aygörmez, E. Erdoğan, and F. M. Kandemir, “Naringin is Protective in Paclitaxel-Induced Peripheral Neuropathy; A Multi-Biomarker Approach”, New Trend Med Sci, vol. 4, no. 3, pp. 149–155, Sept. 2023, doi: 10.56766/ntms.1325124.
ISNAD
Yılmaz, Selçuk - Şimşek, Hasan - Küçükler, Sefa - Aygörmez, Serpil - Erdoğan, Ender - Kandemir, Fatih Mehmet. “Naringin Is Protective in Paclitaxel-Induced Peripheral Neuropathy; A Multi-Biomarker Approach”. New Trends in Medicine Sciences 4/3 (September 1, 2023): 149-155. https://doi.org/10.56766/ntms.1325124.
JAMA
1.Yılmaz S, Şimşek H, Küçükler S, Aygörmez S, Erdoğan E, Kandemir FM. Naringin is Protective in Paclitaxel-Induced Peripheral Neuropathy; A Multi-Biomarker Approach. New Trend Med Sci. 2023;4:149–155.
MLA
Yılmaz, Selçuk, et al. “Naringin Is Protective in Paclitaxel-Induced Peripheral Neuropathy; A Multi-Biomarker Approach”. New Trends in Medicine Sciences, vol. 4, no. 3, Sept. 2023, pp. 149-55, doi:10.56766/ntms.1325124.
Vancouver
1.Selçuk Yılmaz, Hasan Şimşek, Sefa Küçükler, Serpil Aygörmez, Ender Erdoğan, Fatih Mehmet Kandemir. Naringin is Protective in Paclitaxel-Induced Peripheral Neuropathy; A Multi-Biomarker Approach. New Trend Med Sci. 2023 Sep. 1;4(3):149-55. doi:10.56766/ntms.1325124